nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC16A1—Methotrexate—esophageal cancer	0.297	1	CbGbCtD
Niacin—HCAR3—lung—esophageal cancer	0.017	0.114	CbGeAlD
Niacin—HCAR2—lung—esophageal cancer	0.0112	0.0755	CbGeAlD
Niacin—NNMT—bronchus—esophageal cancer	0.00981	0.0658	CbGeAlD
Niacin—NNMT—smooth muscle tissue—esophageal cancer	0.0096	0.0644	CbGeAlD
Niacin—NNMT—trachea—esophageal cancer	0.00881	0.0591	CbGeAlD
Niacin—HCAR2—lymph node—esophageal cancer	0.00769	0.0516	CbGeAlD
Niacin—NNMT—digestive system—esophageal cancer	0.00758	0.0509	CbGeAlD
Niacin—Metyrapone—CYP2A6—esophageal cancer	0.00744	0.653	CrCbGaD
Niacin—SLC16A3—epithelium—esophageal cancer	0.0068	0.0457	CbGeAlD
Niacin—SLC16A3—bronchus—esophageal cancer	0.0067	0.045	CbGeAlD
Niacin—SLC16A3—smooth muscle tissue—esophageal cancer	0.00655	0.044	CbGeAlD
Niacin—Fibrosis—Cisplatin—esophageal cancer	0.00643	0.0327	CcSEcCtD
Niacin—NNMT—lung—esophageal cancer	0.00633	0.0425	CbGeAlD
Niacin—SLC16A3—trachea—esophageal cancer	0.00602	0.0404	CbGeAlD
Niacin—SLC16A3—digestive system—esophageal cancer	0.00518	0.0347	CbGeAlD
Niacin—Hyperkeratosis—Capecitabine—esophageal cancer	0.00474	0.0241	CcSEcCtD
Niacin—Fibrosis—Capecitabine—esophageal cancer	0.00474	0.0241	CcSEcCtD
Niacin—NNMT—lymph node—esophageal cancer	0.00433	0.029	CbGeAlD
Niacin—SLC16A3—lung—esophageal cancer	0.00432	0.029	CbGeAlD
Niacin—SLC16A1—epithelium—esophageal cancer	0.00413	0.0277	CbGeAlD
Niacin—Arterial thrombosis—Methotrexate—esophageal cancer	0.00374	0.019	CcSEcCtD
Niacin—Fibrosis—Methotrexate—esophageal cancer	0.00353	0.0179	CcSEcCtD
Niacin—SLC16A1—digestive system—esophageal cancer	0.00314	0.0211	CbGeAlD
Niacin—Generalised oedema—Cisplatin—esophageal cancer	0.00309	0.0157	CcSEcCtD
Niacin—Ascites—Capecitabine—esophageal cancer	0.00298	0.0151	CcSEcCtD
Niacin—SLC16A3—lymph node—esophageal cancer	0.00296	0.0198	CbGeAlD
Niacin—SLCO2B1—digestive system—esophageal cancer	0.0027	0.0182	CbGeAlD
Niacin—SLC16A1—lung—esophageal cancer	0.00263	0.0176	CbGeAlD
Niacin—Hepatotoxicity—Cisplatin—esophageal cancer	0.00238	0.0121	CcSEcCtD
Niacin—Furunculosis—Methotrexate—esophageal cancer	0.00237	0.012	CcSEcCtD
Niacin—Necrosis—Cisplatin—esophageal cancer	0.00234	0.0119	CcSEcCtD
Niacin—SLC22A5—bronchus—esophageal cancer	0.00233	0.0156	CbGeAlD
Niacin—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.00228	0.0116	CcSEcCtD
Niacin—SLCO2B1—lung—esophageal cancer	0.00226	0.0152	CbGeAlD
Niacin—Raised liver function tests—Methotrexate—esophageal cancer	0.00218	0.0111	CcSEcCtD
Niacin—Hypothyroidism—Capecitabine—esophageal cancer	0.00211	0.0107	CcSEcCtD
Niacin—SLC22A5—trachea—esophageal cancer	0.00209	0.014	CbGeAlD
Niacin—Furuncle—Methotrexate—esophageal cancer	0.00206	0.0104	CcSEcCtD
Niacin—Hyperuricaemia—Cisplatin—esophageal cancer	0.00198	0.0101	CcSEcCtD
Niacin—Salicylic acid—PTGS1—esophageal cancer	0.00192	0.169	CrCbGaD
Niacin—Hepatomegaly—Capecitabine—esophageal cancer	0.00191	0.00972	CcSEcCtD
Niacin—Pain—Carboplatin—esophageal cancer	0.00191	0.00971	CcSEcCtD
Niacin—Laryngitis—Capecitabine—esophageal cancer	0.00188	0.00955	CcSEcCtD
Niacin—Blood uric acid increased—Cisplatin—esophageal cancer	0.00187	0.00951	CcSEcCtD
Niacin—Tongue disorder—Capecitabine—esophageal cancer	0.00186	0.00946	CcSEcCtD
Niacin—Haemoptysis—Capecitabine—esophageal cancer	0.00183	0.0093	CcSEcCtD
Niacin—Herpes zoster—Capecitabine—esophageal cancer	0.0018	0.00914	CcSEcCtD
Niacin—SLC22A5—digestive system—esophageal cancer	0.0018	0.0121	CbGeAlD
Niacin—SLC16A1—lymph node—esophageal cancer	0.0018	0.0121	CbGeAlD
Niacin—Body temperature increased—Carboplatin—esophageal cancer	0.00177	0.00898	CcSEcCtD
Niacin—Skin exfoliation—Cisplatin—esophageal cancer	0.00175	0.00891	CcSEcCtD
Niacin—Hepatotoxicity—Capecitabine—esophageal cancer	0.00175	0.00891	CcSEcCtD
Niacin—Fluid retention—Cisplatin—esophageal cancer	0.00174	0.00886	CcSEcCtD
Niacin—Skin ulcer—Capecitabine—esophageal cancer	0.00174	0.00884	CcSEcCtD
Niacin—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.0017	0.00861	CcSEcCtD
Niacin—Tingling sensation—Capecitabine—esophageal cancer	0.00168	0.00856	CcSEcCtD
Niacin—SLCO2B1—lymph node—esophageal cancer	0.00154	0.0104	CbGeAlD
Niacin—Polyuria—Cisplatin—esophageal cancer	0.00152	0.00772	CcSEcCtD
Niacin—SLC22A5—lung—esophageal cancer	0.0015	0.0101	CbGeAlD
Niacin—Skin discolouration—Capecitabine—esophageal cancer	0.0015	0.00762	CcSEcCtD
Niacin—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00149	0.00757	CcSEcCtD
Niacin—Burning sensation—Methotrexate—esophageal cancer	0.00145	0.00737	CcSEcCtD
Niacin—Lung disorder—Methotrexate—esophageal cancer	0.00142	0.00724	CcSEcCtD
Niacin—Herpes zoster—Methotrexate—esophageal cancer	0.00134	0.0068	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00133	0.00678	CcSEcCtD
Niacin—Hepatotoxicity—Methotrexate—esophageal cancer	0.00131	0.00663	CcSEcCtD
Niacin—Skin ulcer—Methotrexate—esophageal cancer	0.0013	0.00658	CcSEcCtD
Niacin—Skin exfoliation—Capecitabine—esophageal cancer	0.00129	0.00657	CcSEcCtD
Niacin—Face oedema—Cisplatin—esophageal cancer	0.00129	0.00654	CcSEcCtD
Niacin—Fluid retention—Capecitabine—esophageal cancer	0.00129	0.00653	CcSEcCtD
Niacin—Necrosis—Methotrexate—esophageal cancer	0.00128	0.00653	CcSEcCtD
Niacin—Oesophagitis—Capecitabine—esophageal cancer	0.00124	0.00629	CcSEcCtD
Niacin—Urine output increased—Capecitabine—esophageal cancer	0.00122	0.00622	CcSEcCtD
Niacin—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00122	0.00619	CcSEcCtD
Niacin—Abnormal vision—Capecitabine—esophageal cancer	0.00118	0.006	CcSEcCtD
Niacin—CYP2D6—digestive system—esophageal cancer	0.00116	0.00778	CbGeAlD
Niacin—Diabetes mellitus—Capecitabine—esophageal cancer	0.00113	0.00574	CcSEcCtD
Niacin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00113	0.00572	CcSEcCtD
Niacin—Polyuria—Capecitabine—esophageal cancer	0.00112	0.00569	CcSEcCtD
Niacin—Bone disorder—Methotrexate—esophageal cancer	0.00112	0.00567	CcSEcCtD
Niacin—Skin discolouration—Methotrexate—esophageal cancer	0.00112	0.00567	CcSEcCtD
Niacin—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00111	0.00563	CcSEcCtD
Niacin—Salicylic acid—PTGS2—esophageal cancer	0.0011	0.0964	CrCbGaD
Niacin—Hyperuricaemia—Methotrexate—esophageal cancer	0.00109	0.00552	CcSEcCtD
Niacin—Atrial fibrillation—Capecitabine—esophageal cancer	0.00104	0.00527	CcSEcCtD
Niacin—Dermatitis bullous—Capecitabine—esophageal cancer	0.00103	0.00523	CcSEcCtD
Niacin—Blood uric acid increased—Methotrexate—esophageal cancer	0.00103	0.00522	CcSEcCtD
Niacin—SLC22A5—lymph node—esophageal cancer	0.00103	0.00689	CbGeAlD
Niacin—Arthritis—Capecitabine—esophageal cancer	0.00101	0.00514	CcSEcCtD
Niacin—Vaginal inflammation—Methotrexate—esophageal cancer	0.00101	0.00512	CcSEcCtD
Niacin—Stomatitis—Cisplatin—esophageal cancer	0.001	0.00509	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000983	0.00499	CcSEcCtD
Niacin—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000975	0.00496	CcSEcCtD
Niacin—Migraine—Capecitabine—esophageal cancer	0.000968	0.00492	CcSEcCtD
Niacin—Skin exfoliation—Methotrexate—esophageal cancer	0.000963	0.00489	CcSEcCtD
Niacin—Vaginal infection—Methotrexate—esophageal cancer	0.000952	0.00484	CcSEcCtD
Niacin—Face oedema—Capecitabine—esophageal cancer	0.000949	0.00482	CcSEcCtD
Niacin—Urinary retention—Capecitabine—esophageal cancer	0.000935	0.00475	CcSEcCtD
Niacin—Salicylic acid—ABCB1—esophageal cancer	0.000934	0.0819	CrCbGaD
Niacin—Urine output increased—Methotrexate—esophageal cancer	0.000912	0.00463	CcSEcCtD
Niacin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000908	0.00461	CcSEcCtD
Niacin—Dry skin—Capecitabine—esophageal cancer	0.000901	0.00458	CcSEcCtD
Niacin—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000898	0.00456	CcSEcCtD
Niacin—Visual impairment—Cisplatin—esophageal cancer	0.000889	0.00452	CcSEcCtD
Niacin—Muscular weakness—Capecitabine—esophageal cancer	0.000867	0.00441	CcSEcCtD
Niacin—Eye disorder—Cisplatin—esophageal cancer	0.000862	0.00438	CcSEcCtD
Niacin—Tinnitus—Cisplatin—esophageal cancer	0.00086	0.00437	CcSEcCtD
Niacin—Flushing—Cisplatin—esophageal cancer	0.000856	0.00435	CcSEcCtD
Niacin—Abdominal distension—Capecitabine—esophageal cancer	0.000855	0.00435	CcSEcCtD
Niacin—Influenza—Capecitabine—esophageal cancer	0.00085	0.00432	CcSEcCtD
Niacin—Dysphagia—Capecitabine—esophageal cancer	0.00085	0.00432	CcSEcCtD
Niacin—Diabetes mellitus—Methotrexate—esophageal cancer	0.000841	0.00427	CcSEcCtD
Niacin—Polyuria—Methotrexate—esophageal cancer	0.000834	0.00423	CcSEcCtD
Niacin—Angina pectoris—Capecitabine—esophageal cancer	0.000828	0.00421	CcSEcCtD
Niacin—Arrhythmia—Cisplatin—esophageal cancer	0.000824	0.00419	CcSEcCtD
Niacin—Bronchitis—Capecitabine—esophageal cancer	0.000817	0.00415	CcSEcCtD
Niacin—Alopecia—Cisplatin—esophageal cancer	0.000815	0.00414	CcSEcCtD
Niacin—Malnutrition—Cisplatin—esophageal cancer	0.000803	0.00408	CcSEcCtD
Niacin—Erythema—Cisplatin—esophageal cancer	0.000803	0.00408	CcSEcCtD
Niacin—Flatulence—Cisplatin—esophageal cancer	0.000791	0.00402	CcSEcCtD
Niacin—Muscle spasms—Cisplatin—esophageal cancer	0.000772	0.00392	CcSEcCtD
Niacin—Vision blurred—Cisplatin—esophageal cancer	0.000757	0.00385	CcSEcCtD
Niacin—Stomatitis—Capecitabine—esophageal cancer	0.000739	0.00375	CcSEcCtD
Niacin—Jaundice—Capecitabine—esophageal cancer	0.000739	0.00375	CcSEcCtD
Niacin—Leukopenia—Cisplatin—esophageal cancer	0.000719	0.00365	CcSEcCtD
Niacin—Myalgia—Cisplatin—esophageal cancer	0.000684	0.00347	CcSEcCtD
Niacin—Haemoglobin—Capecitabine—esophageal cancer	0.000684	0.00347	CcSEcCtD
Niacin—Rhinitis—Capecitabine—esophageal cancer	0.000682	0.00346	CcSEcCtD
Niacin—Hepatitis—Capecitabine—esophageal cancer	0.00068	0.00346	CcSEcCtD
Niacin—Haemorrhage—Capecitabine—esophageal cancer	0.00068	0.00346	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000679	0.00345	CcSEcCtD
Niacin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000677	0.00344	CcSEcCtD
Niacin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000676	0.00343	CcSEcCtD
Niacin—Oedema peripheral—Capecitabine—esophageal cancer	0.00067	0.0034	CcSEcCtD
Niacin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000656	0.00333	CcSEcCtD
Niacin—Oedema—Cisplatin—esophageal cancer	0.000656	0.00333	CcSEcCtD
Niacin—Visual impairment—Capecitabine—esophageal cancer	0.000655	0.00333	CcSEcCtD
Niacin—Tachycardia—Cisplatin—esophageal cancer	0.00064	0.00325	CcSEcCtD
Niacin—Skin disorder—Cisplatin—esophageal cancer	0.000637	0.00323	CcSEcCtD
Niacin—Eye disorder—Capecitabine—esophageal cancer	0.000636	0.00323	CcSEcCtD
Niacin—Tinnitus—Capecitabine—esophageal cancer	0.000634	0.00322	CcSEcCtD
Niacin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000634	0.00322	CcSEcCtD
Niacin—Flushing—Capecitabine—esophageal cancer	0.000631	0.00321	CcSEcCtD
Niacin—Anorexia—Cisplatin—esophageal cancer	0.000625	0.00317	CcSEcCtD
Niacin—Angiopathy—Capecitabine—esophageal cancer	0.000617	0.00313	CcSEcCtD
Niacin—Hypotension—Cisplatin—esophageal cancer	0.000613	0.00311	CcSEcCtD
Niacin—Chills—Capecitabine—esophageal cancer	0.00061	0.0031	CcSEcCtD
Niacin—Arrhythmia—Capecitabine—esophageal cancer	0.000608	0.00309	CcSEcCtD
Niacin—Alopecia—Capecitabine—esophageal cancer	0.000601	0.00305	CcSEcCtD
Niacin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000597	0.00303	CcSEcCtD
Niacin—Erythema—Capecitabine—esophageal cancer	0.000592	0.00301	CcSEcCtD
Niacin—Malnutrition—Capecitabine—esophageal cancer	0.000592	0.00301	CcSEcCtD
Niacin—Paraesthesia—Cisplatin—esophageal cancer	0.000589	0.00299	CcSEcCtD
Niacin—Dyspnoea—Cisplatin—esophageal cancer	0.000584	0.00297	CcSEcCtD
Niacin—Flatulence—Capecitabine—esophageal cancer	0.000583	0.00296	CcSEcCtD
Niacin—Erectile dysfunction—Methotrexate—esophageal cancer	0.000583	0.00296	CcSEcCtD
Niacin—Decreased appetite—Cisplatin—esophageal cancer	0.00057	0.00289	CcSEcCtD
Niacin—Muscle spasms—Capecitabine—esophageal cancer	0.000569	0.00289	CcSEcCtD
Niacin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000566	0.00288	CcSEcCtD
Niacin—Pain—Cisplatin—esophageal cancer	0.000561	0.00285	CcSEcCtD
Niacin—Vision blurred—Capecitabine—esophageal cancer	0.000558	0.00283	CcSEcCtD
Niacin—Stomatitis—Methotrexate—esophageal cancer	0.00055	0.00279	CcSEcCtD
Niacin—Sweating—Methotrexate—esophageal cancer	0.000541	0.00275	CcSEcCtD
Niacin—Vertigo—Capecitabine—esophageal cancer	0.000532	0.0027	CcSEcCtD
Niacin—Syncope—Capecitabine—esophageal cancer	0.000531	0.0027	CcSEcCtD
Niacin—Leukopenia—Capecitabine—esophageal cancer	0.00053	0.00269	CcSEcCtD
Niacin—Palpitations—Capecitabine—esophageal cancer	0.000523	0.00266	CcSEcCtD
Niacin—Loss of consciousness—Capecitabine—esophageal cancer	0.00052	0.00264	CcSEcCtD
Niacin—Body temperature increased—Cisplatin—esophageal cancer	0.000518	0.00263	CcSEcCtD
Niacin—Cough—Capecitabine—esophageal cancer	0.000517	0.00262	CcSEcCtD
Niacin—Haemoglobin—Methotrexate—esophageal cancer	0.000509	0.00259	CcSEcCtD
Niacin—Hepatitis—Methotrexate—esophageal cancer	0.000506	0.00257	CcSEcCtD
Niacin—Haemorrhage—Methotrexate—esophageal cancer	0.000506	0.00257	CcSEcCtD
Niacin—Myalgia—Capecitabine—esophageal cancer	0.000504	0.00256	CcSEcCtD
Niacin—Arthralgia—Capecitabine—esophageal cancer	0.000504	0.00256	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000501	0.00254	CcSEcCtD
Niacin—Dry mouth—Capecitabine—esophageal cancer	0.000493	0.0025	CcSEcCtD
Niacin—Visual impairment—Methotrexate—esophageal cancer	0.000488	0.00248	CcSEcCtD
Niacin—Oedema—Capecitabine—esophageal cancer	0.000483	0.00245	CcSEcCtD
Niacin—Hypersensitivity—Cisplatin—esophageal cancer	0.000483	0.00245	CcSEcCtD
Niacin—Shock—Capecitabine—esophageal cancer	0.000475	0.00242	CcSEcCtD
Niacin—Eye disorder—Methotrexate—esophageal cancer	0.000473	0.0024	CcSEcCtD
Niacin—Tinnitus—Methotrexate—esophageal cancer	0.000472	0.0024	CcSEcCtD
Niacin—Tachycardia—Capecitabine—esophageal cancer	0.000472	0.0024	CcSEcCtD
Niacin—Asthenia—Cisplatin—esophageal cancer	0.00047	0.00239	CcSEcCtD
Niacin—Skin disorder—Capecitabine—esophageal cancer	0.000469	0.00238	CcSEcCtD
Niacin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000467	0.00237	CcSEcCtD
Niacin—Anorexia—Capecitabine—esophageal cancer	0.000461	0.00234	CcSEcCtD
Niacin—Angiopathy—Methotrexate—esophageal cancer	0.000459	0.00233	CcSEcCtD
Niacin—Chills—Methotrexate—esophageal cancer	0.000454	0.00231	CcSEcCtD
Niacin—Hypotension—Capecitabine—esophageal cancer	0.000452	0.00229	CcSEcCtD
Niacin—Diarrhoea—Cisplatin—esophageal cancer	0.000449	0.00228	CcSEcCtD
Niacin—Alopecia—Methotrexate—esophageal cancer	0.000447	0.00227	CcSEcCtD
Niacin—Malnutrition—Methotrexate—esophageal cancer	0.000441	0.00224	CcSEcCtD
Niacin—Erythema—Methotrexate—esophageal cancer	0.000441	0.00224	CcSEcCtD
Niacin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00044	0.00224	CcSEcCtD
Niacin—Insomnia—Capecitabine—esophageal cancer	0.000437	0.00222	CcSEcCtD
Niacin—Paraesthesia—Capecitabine—esophageal cancer	0.000434	0.0022	CcSEcCtD
Niacin—Dyspnoea—Capecitabine—esophageal cancer	0.000431	0.00219	CcSEcCtD
Niacin—Dyspepsia—Capecitabine—esophageal cancer	0.000425	0.00216	CcSEcCtD
Niacin—Decreased appetite—Capecitabine—esophageal cancer	0.00042	0.00213	CcSEcCtD
Niacin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000417	0.00212	CcSEcCtD
Niacin—Vomiting—Cisplatin—esophageal cancer	0.000417	0.00212	CcSEcCtD
Niacin—Vision blurred—Methotrexate—esophageal cancer	0.000415	0.00211	CcSEcCtD
Niacin—Rash—Cisplatin—esophageal cancer	0.000413	0.0021	CcSEcCtD
Niacin—Pain—Capecitabine—esophageal cancer	0.000413	0.0021	CcSEcCtD
Niacin—Dermatitis—Cisplatin—esophageal cancer	0.000413	0.0021	CcSEcCtD
Niacin—Vertigo—Methotrexate—esophageal cancer	0.000396	0.00201	CcSEcCtD
Niacin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000395	0.00201	CcSEcCtD
Niacin—Leukopenia—Methotrexate—esophageal cancer	0.000395	0.002	CcSEcCtD
Niacin—Nausea—Cisplatin—esophageal cancer	0.000389	0.00198	CcSEcCtD
Niacin—Cough—Methotrexate—esophageal cancer	0.000385	0.00195	CcSEcCtD
Niacin—Urticaria—Capecitabine—esophageal cancer	0.000384	0.00195	CcSEcCtD
Niacin—Abdominal pain—Capecitabine—esophageal cancer	0.000382	0.00194	CcSEcCtD
Niacin—Body temperature increased—Capecitabine—esophageal cancer	0.000382	0.00194	CcSEcCtD
Niacin—Arthralgia—Methotrexate—esophageal cancer	0.000375	0.00191	CcSEcCtD
Niacin—Myalgia—Methotrexate—esophageal cancer	0.000375	0.00191	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000373	0.00189	CcSEcCtD
Niacin—Anaphylactic shock—Methotrexate—esophageal cancer	0.00036	0.00183	CcSEcCtD
Niacin—Hypersensitivity—Capecitabine—esophageal cancer	0.000356	0.00181	CcSEcCtD
Niacin—Skin disorder—Methotrexate—esophageal cancer	0.000349	0.00178	CcSEcCtD
Niacin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000348	0.00177	CcSEcCtD
Niacin—Asthenia—Capecitabine—esophageal cancer	0.000347	0.00176	CcSEcCtD
Niacin—Anorexia—Methotrexate—esophageal cancer	0.000343	0.00174	CcSEcCtD
Niacin—Pruritus—Capecitabine—esophageal cancer	0.000342	0.00174	CcSEcCtD
Niacin—Hypotension—Methotrexate—esophageal cancer	0.000336	0.00171	CcSEcCtD
Niacin—Diarrhoea—Capecitabine—esophageal cancer	0.000331	0.00168	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000328	0.00166	CcSEcCtD
Niacin—Insomnia—Methotrexate—esophageal cancer	0.000325	0.00165	CcSEcCtD
Niacin—Paraesthesia—Methotrexate—esophageal cancer	0.000323	0.00164	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000323	0.000933	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GNG7—esophageal cancer	0.000321	0.000928	CbGpPWpGaD
Niacin—Dyspnoea—Methotrexate—esophageal cancer	0.000321	0.00163	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PDE4D—esophageal cancer	0.00032	0.000925	CbGpPWpGaD
Niacin—Somnolence—Methotrexate—esophageal cancer	0.00032	0.00162	CcSEcCtD
Niacin—Dizziness—Capecitabine—esophageal cancer	0.00032	0.00162	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—esophageal cancer	0.000317	0.00161	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000314	0.000909	CbGpPWpGaD
Niacin—Decreased appetite—Methotrexate—esophageal cancer	0.000313	0.00159	CcSEcCtD
Niacin—QPRT—Metabolism—CYP1B1—esophageal cancer	0.000312	0.000902	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000311	0.00158	CcSEcCtD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00031	0.000895	CbGpPWpGaD
Niacin—Pain—Methotrexate—esophageal cancer	0.000308	0.00156	CcSEcCtD
Niacin—Vomiting—Capecitabine—esophageal cancer	0.000307	0.00156	CcSEcCtD
Niacin—QPRT—Disease—SMAD4—esophageal cancer	0.000307	0.000887	CbGpPWpGaD
Niacin—Rash—Capecitabine—esophageal cancer	0.000305	0.00155	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—GNG7—esophageal cancer	0.000304	0.00088	CbGpPWpGaD
Niacin—Dermatitis—Capecitabine—esophageal cancer	0.000304	0.00155	CcSEcCtD
Niacin—Headache—Capecitabine—esophageal cancer	0.000303	0.00154	CcSEcCtD
Niacin—SLC16A3—Metabolism—PLCE1—esophageal cancer	0.000303	0.000874	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ADH7—esophageal cancer	0.000303	0.000874	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—XIAP—esophageal cancer	0.000301	0.00087	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.0003	0.000867	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—ABL1—esophageal cancer	0.000297	0.000859	CbGpPWpGaD
Niacin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000294	0.00149	CcSEcCtD
Niacin—QPRT—Metabolism—CYP19A1—esophageal cancer	0.000293	0.000848	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000291	0.000841	CbGpPWpGaD
Niacin—NNMT—Metabolism—CYP1B1—esophageal cancer	0.00029	0.000838	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000289	0.000836	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000288	0.000831	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000288	0.000831	CbGpPWpGaD
Niacin—Nausea—Capecitabine—esophageal cancer	0.000287	0.00146	CcSEcCtD
Niacin—Urticaria—Methotrexate—esophageal cancer	0.000286	0.00145	CcSEcCtD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000286	0.000825	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000285	0.000824	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—XIAP—esophageal cancer	0.000285	0.000824	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNA1—esophageal cancer	0.000285	0.000822	CbGpPWpGaD
Niacin—Body temperature increased—Methotrexate—esophageal cancer	0.000284	0.00144	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—esophageal cancer	0.000284	0.00144	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CXCL2—esophageal cancer	0.000283	0.000818	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CFL1—esophageal cancer	0.000282	0.000815	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000276	0.000797	CbGpPWpGaD
Niacin—NNMT—Metabolism—CYP19A1—esophageal cancer	0.000273	0.000788	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000272	0.000786	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNA1—esophageal cancer	0.00027	0.00078	CbGpPWpGaD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000269	0.000776	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL2—esophageal cancer	0.000268	0.000775	CbGpPWpGaD
Niacin—QPRT—Metabolism—HMOX1—esophageal cancer	0.000268	0.000774	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.000266	0.000769	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—GNG7—esophageal cancer	0.000266	0.000768	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ADH1B—esophageal cancer	0.000265	0.000767	CbGpPWpGaD
Niacin—Hypersensitivity—Methotrexate—esophageal cancer	0.000265	0.00135	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PSME2—esophageal cancer	0.000264	0.000764	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PSME1—esophageal cancer	0.000264	0.000764	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ANXA1—esophageal cancer	0.000263	0.00076	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00026	0.00075	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000259	0.000748	CbGpPWpGaD
Niacin—Asthenia—Methotrexate—esophageal cancer	0.000258	0.00131	CcSEcCtD
Niacin—QPRT—Metabolism—ABCB1—esophageal cancer	0.000257	0.000743	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SST—esophageal cancer	0.000256	0.000739	CbGpPWpGaD
Niacin—Pruritus—Methotrexate—esophageal cancer	0.000255	0.00129	CcSEcCtD
Niacin—SLC16A3—Metabolism—TYMP—esophageal cancer	0.000254	0.000733	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000253	0.000733	CbGpPWpGaD
Niacin—QPRT—Disease—HIF1A—esophageal cancer	0.000251	0.000726	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PSME1—esophageal cancer	0.000251	0.000724	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PSME2—esophageal cancer	0.000251	0.000724	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ANXA1—esophageal cancer	0.000249	0.000721	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GHRL—esophageal cancer	0.000249	0.000721	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOTCH3—esophageal cancer	0.000249	0.000721	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000249	0.00072	CbGpPWpGaD
Niacin—NNMT—Metabolism—HMOX1—esophageal cancer	0.000249	0.000719	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP26A1—esophageal cancer	0.000247	0.000713	CbGpPWpGaD
Niacin—Diarrhoea—Methotrexate—esophageal cancer	0.000246	0.00125	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—FBXW7—esophageal cancer	0.000245	0.000709	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SST—esophageal cancer	0.000243	0.000701	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALOX15—esophageal cancer	0.00024	0.000695	CbGpPWpGaD
Niacin—NNMT—Metabolism—ABCB1—esophageal cancer	0.000239	0.00069	CbGpPWpGaD
Niacin—Dizziness—Methotrexate—esophageal cancer	0.000238	0.00121	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—GHRL—esophageal cancer	0.000236	0.000683	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOTCH3—esophageal cancer	0.000236	0.000683	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000235	0.000678	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.000233	0.000674	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FBXW7—esophageal cancer	0.000233	0.000672	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00023	0.000665	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTO1—esophageal cancer	0.000229	0.000663	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TPI1—esophageal cancer	0.000229	0.000663	CbGpPWpGaD
Niacin—Vomiting—Methotrexate—esophageal cancer	0.000229	0.00116	CcSEcCtD
Niacin—QPRT—Disease—NOS2—esophageal cancer	0.000228	0.00066	CbGpPWpGaD
Niacin—Rash—Methotrexate—esophageal cancer	0.000227	0.00115	CcSEcCtD
Niacin—Dermatitis—Methotrexate—esophageal cancer	0.000227	0.00115	CcSEcCtD
Niacin—QPRT—Disease—NOTCH1—esophageal cancer	0.000226	0.000654	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BLVRB—esophageal cancer	0.000226	0.000653	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC52A3—esophageal cancer	0.000226	0.000653	CbGpPWpGaD
Niacin—Headache—Methotrexate—esophageal cancer	0.000225	0.00114	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—NOTCH2—esophageal cancer	0.000224	0.000646	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000221	0.000637	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALDOB—esophageal cancer	0.00022	0.000635	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000218	0.00063	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.000217	0.000627	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HSPA5—esophageal cancer	0.000217	0.000626	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NOS2—esophageal cancer	0.000214	0.000619	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000214	0.000618	CbGpPWpGaD
Niacin—Nausea—Methotrexate—esophageal cancer	0.000214	0.00109	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—NOTCH2—esophageal cancer	0.000212	0.000613	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GAPDH—esophageal cancer	0.000212	0.000612	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CRABP1—esophageal cancer	0.00021	0.000606	CbGpPWpGaD
Niacin—QPRT—Disease—CREBBP—esophageal cancer	0.000205	0.000593	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.000202	0.000583	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GNG7—esophageal cancer	0.0002	0.000577	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.000199	0.000575	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFBR2—esophageal cancer	0.000198	0.000573	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000198	0.000572	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—esophageal cancer	0.000193	0.000558	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—CREBBP—esophageal cancer	0.000192	0.000556	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CA1—esophageal cancer	0.000192	0.000555	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC10A2—esophageal cancer	0.000192	0.000555	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFBR2—esophageal cancer	0.000188	0.000544	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SMAD4—esophageal cancer	0.000188	0.000543	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALDH2—esophageal cancer	0.000187	0.00054	CbGpPWpGaD
Niacin—QPRT—Disease—NOS3—esophageal cancer	0.000184	0.000531	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SMAD4—esophageal cancer	0.000178	0.000515	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTT1—esophageal cancer	0.000178	0.000514	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP2A6—esophageal cancer	0.000176	0.000508	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CA2—esophageal cancer	0.000176	0.000508	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NOS3—esophageal cancer	0.000172	0.000498	CbGpPWpGaD
Niacin—QPRT—Metabolism—CREBBP—esophageal cancer	0.000172	0.000496	CbGpPWpGaD
Niacin—QPRT—Disease—ERBB2—esophageal cancer	0.000172	0.000496	CbGpPWpGaD
Niacin—QPRT—Disease—PTGS2—esophageal cancer	0.000168	0.000485	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ENO1—esophageal cancer	0.000167	0.000481	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS1—esophageal cancer	0.000167	0.000481	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000166	0.000481	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000164	0.000475	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PSME2—esophageal cancer	0.000164	0.000474	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PSME1—esophageal cancer	0.000164	0.000474	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PLCE1—esophageal cancer	0.000163	0.000472	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ADH7—esophageal cancer	0.000163	0.000472	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ABL1—esophageal cancer	0.00016	0.000464	CbGpPWpGaD
Niacin—NNMT—Metabolism—CREBBP—esophageal cancer	0.00016	0.000461	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000158	0.000456	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000156	0.000452	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000155	0.000447	CbGpPWpGaD
Niacin—QPRT—Metabolism—NOS3—esophageal cancer	0.000154	0.000444	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HIF1A—esophageal cancer	0.000154	0.000444	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000151	0.000438	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KDR—esophageal cancer	0.000147	0.000425	CbGpPWpGaD
Niacin—QPRT—Disease—CDKN1A—esophageal cancer	0.000147	0.000424	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000147	0.000424	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HIF1A—esophageal cancer	0.000146	0.000421	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ADH1B—esophageal cancer	0.000143	0.000414	CbGpPWpGaD
Niacin—NNMT—Metabolism—NOS3—esophageal cancer	0.000143	0.000413	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP1B1—esophageal cancer	0.000142	0.000409	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTGS2—esophageal cancer	0.000141	0.000406	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00014	0.000405	CbGpPWpGaD
Niacin—QPRT—Disease—EP300—esophageal cancer	0.00014	0.000404	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KDR—esophageal cancer	0.000139	0.000403	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOTCH1—esophageal cancer	0.000138	0.0004	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TYMP—esophageal cancer	0.000137	0.000396	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000135	0.000389	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP19A1—esophageal cancer	0.000133	0.000385	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP26A1—esophageal cancer	0.000133	0.000385	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOTCH1—esophageal cancer	0.000131	0.000379	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—EP300—esophageal cancer	0.000131	0.000379	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—esophageal cancer	0.000131	0.000378	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALOX15—esophageal cancer	0.00013	0.000375	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CREBBP—esophageal cancer	0.000126	0.000363	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000125	0.00036	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TPI1—esophageal cancer	0.000124	0.000358	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTO1—esophageal cancer	0.000124	0.000358	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—esophageal cancer	0.000123	0.000356	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000123	0.000355	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—esophageal cancer	0.000122	0.000352	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HMOX1—esophageal cancer	0.000122	0.000351	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000121	0.000348	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—esophageal cancer	0.000119	0.000344	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CREBBP—esophageal cancer	0.000119	0.000344	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALDOB—esophageal cancer	0.000119	0.000343	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000118	0.000341	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000117	0.000339	CbGpPWpGaD
Niacin—QPRT—Metabolism—EP300—esophageal cancer	0.000117	0.000338	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—esophageal cancer	0.000117	0.000338	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ABCB1—esophageal cancer	0.000117	0.000337	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000116	0.000334	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS2—esophageal cancer	0.000116	0.000334	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000116	0.000334	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GAPDH—esophageal cancer	0.000114	0.00033	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CRABP1—esophageal cancer	0.000113	0.000327	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOS3—esophageal cancer	0.000112	0.000325	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000112	0.000323	CbGpPWpGaD
Niacin—NNMT—Metabolism—EP300—esophageal cancer	0.000109	0.000314	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GNG7—esophageal cancer	0.000108	0.000311	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—esophageal cancer	0.000107	0.000309	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOS3—esophageal cancer	0.000107	0.000308	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—esophageal cancer	0.000105	0.000304	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CREBBP—esophageal cancer	0.000104	0.0003	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—esophageal cancer	0.000103	0.000299	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—esophageal cancer	0.000101	0.000293	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000101	0.000292	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALDH2—esophageal cancer	0.000101	0.000292	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—esophageal cancer	9.97e-05	0.000288	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—esophageal cancer	9.69e-05	0.00028	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTT1—esophageal cancer	9.6e-05	0.000277	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2A6—esophageal cancer	9.49e-05	0.000274	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—esophageal cancer	9.37e-05	0.000271	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS3—esophageal cancer	9.3e-05	0.000269	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—esophageal cancer	9.29e-05	0.000268	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS1—esophageal cancer	9e-05	0.00026	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ENO1—esophageal cancer	9e-05	0.00026	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.99e-05	0.00026	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1A—esophageal cancer	8.98e-05	0.00026	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PSME1—esophageal cancer	8.87e-05	0.000256	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PSME2—esophageal cancer	8.87e-05	0.000256	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—esophageal cancer	8.8e-05	0.000254	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—esophageal cancer	8.65e-05	0.00025	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EP300—esophageal cancer	8.55e-05	0.000247	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1A—esophageal cancer	8.52e-05	0.000246	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EP300—esophageal cancer	8.1e-05	0.000234	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—esophageal cancer	8.04e-05	0.000232	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CREBBP—esophageal cancer	7.8e-05	0.000225	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.73e-05	0.000223	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1B1—esophageal cancer	7.65e-05	0.000221	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—esophageal cancer	7.45e-05	0.000215	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—esophageal cancer	7.29e-05	0.000211	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP19A1—esophageal cancer	7.19e-05	0.000208	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EP300—esophageal cancer	7.07e-05	0.000204	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—esophageal cancer	7.06e-05	0.000204	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NOS3—esophageal cancer	6.98e-05	0.000202	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—esophageal cancer	6.91e-05	0.0002	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HMOX1—esophageal cancer	6.56e-05	0.00019	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—esophageal cancer	6.39e-05	0.000185	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—esophageal cancer	6.32e-05	0.000183	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCB1—esophageal cancer	6.3e-05	0.000182	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BLVRB—esophageal cancer	6.3e-05	0.000182	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC52A3—esophageal cancer	6.3e-05	0.000182	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—esophageal cancer	6.12e-05	0.000177	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—esophageal cancer	6e-05	0.000173	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—esophageal cancer	5.8e-05	0.000168	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CA1—esophageal cancer	5.35e-05	0.000155	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC10A2—esophageal cancer	5.35e-05	0.000155	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—EP300—esophageal cancer	5.31e-05	0.000153	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—esophageal cancer	5.23e-05	0.000151	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—esophageal cancer	5.06e-05	0.000146	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CA2—esophageal cancer	4.9e-05	0.000141	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADH7—esophageal cancer	4.55e-05	0.000132	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLCE1—esophageal cancer	4.55e-05	0.000132	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CREBBP—esophageal cancer	4.21e-05	0.000122	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADH1B—esophageal cancer	3.99e-05	0.000115	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—esophageal cancer	3.93e-05	0.000114	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMP—esophageal cancer	3.81e-05	0.00011	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NOS3—esophageal cancer	3.77e-05	0.000109	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP26A1—esophageal cancer	3.71e-05	0.000107	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALOX15—esophageal cancer	3.62e-05	0.000104	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TPI1—esophageal cancer	3.45e-05	9.97e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.45e-05	9.97e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—esophageal cancer	3.45e-05	9.96e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.31e-05	9.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.18e-05	9.2e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.16e-05	9.12e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNG7—esophageal cancer	3e-05	8.67e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—EP300—esophageal cancer	2.87e-05	8.29e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.81e-05	8.13e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.67e-05	7.73e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.64e-05	7.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.51e-05	7.24e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ENO1—esophageal cancer	2.51e-05	7.24e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PSME2—esophageal cancer	2.47e-05	7.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PSME1—esophageal cancer	2.47e-05	7.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.13e-05	6.16e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—esophageal cancer	2.12e-05	6.13e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2e-05	5.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.83e-05	5.28e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.76e-05	5.07e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.17e-05	3.39e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NOS3—esophageal cancer	1.05e-05	3.03e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—esophageal cancer	9.61e-06	2.78e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—EP300—esophageal cancer	7.99e-06	2.31e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—esophageal cancer	5.91e-06	1.71e-05	CbGpPWpGaD
